Irbesartan | 厄贝沙坦 | BMS-186295 | Angiotensin Receptor Antagonist

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT00741702	Hypertension ... 展开 >>Diabetes Mellitus 收起 <<	Not Applicable	Completed	-	-
NCT01195818	Sickle Cell Disease	Not Applicable	Completed	-	France ... 展开 >> Centre de la Drépanocytose, Service de Médecine Interne. Hôpital Tenon, 4 Rue de la Chine Paris, France, 75020 收起 <<
NCT01715207	Marfan Syndrome	Phase 3	Completed	-	Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 <<
NCT01715207	-		Completed	-	-
NCT02973035	Hypertension	Phase 4	Recruiting	June 2019	Korea, Republic of ... 展开 >> Busan Baik Hospital Recruiting Busan, Korea, Republic of Contact: Jeong-Suk Seo, M.D. orifilter@hanmail.net Busan University Hospital Recruiting Busan, Korea, Republic of Contact: Yong-Hyun Park nadroj@chol.com Chungnam University Hospital Recruiting Daejeon, Korea, Republic of Contact: Jae-Hyung Park, M.D. jaehpark@cnuh.co.kr Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Duk-Hyun Kang, M.D. dhkang@amc.seoul.kr 收起 <<
NCT00361023	Type 2 Diabetes ... 展开 >> Diabetic Nephropathy 收起 <<	Not Applicable	Completed	-	-
NCT01805362	Chronic Kidney Disease	Not Applicable	Unknown	February 2017	France ... 展开 >> Department of Nephrology, Nice University Hospital Recruiting Nice, France, 06000 Contact: vincent Esnault, MD esnault.v@chu-nice.fr Principal Investigator: Vincent Esnault, MD 收起 <<
NCT00212901	Diabetic Kidney Disease	Not Applicable	Completed	-	Canada, Ontario ... 展开 >> The Ottawa Hospital Ottawa, Ontario, Canada, K1H 7W9 收起 <<
NCT00794963	Metabolic Syndrome	Not Applicable	Terminated(Difficulty recruiti... 展开 >>ng) 收起 <<	-	United States, New York ... 展开 >> Zucker Hillside Hospital Glen Oaks, New York, United States, 11004 收起 <<
NCT00794963	-		Terminated(Difficulty recruiti... 展开 >>ng) 收起 <<	-	-
NCT00180024	Healthy Subjects	Not Applicable	Completed	-	Germany ... 展开 >> Institute of Clinical Pharmacology, Medical Faculty, University of Technology Dresden, Germany, 01307 收起 <<
NCT00657059	IgA Nephropathy	Phase 3	Active, not recruiting	April 2019	China, Guangdong ... 展开 >> The 1st Affiliated Hospital, Sun Yet-sen University Guangzhou, Guangdong, China, 510080 收起 <<
NCT01500590	Diabetes Hype... 展开 >>rtensive Disease 收起 <<	Phase 4	Active, not recruiting	August 2019	China ... 展开 >> Hospital Authority, HKEC, FM&PHC Hong Kong, China 收起 <<
NCT02644486	Obesity and Glomerulopathy	Not Applicable	Terminated(difficulty in enrol... 展开 >>lment) 收起 <<	-	China, Jiangsu ... 展开 >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 收起 <<
NCT02380625	Ebola Virus Disease	Phase 1 Phase 2	Unknown	March 2016	-
NCT00106561	Kidney Disease ... 展开 >> Diabetic Nephropathy Glomerulonephritis Proteinuria 收起 <<	Phase 2 Phase 3	Completed	-	Australia, Victoria ... 展开 >> Department of Nephrology, The Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 收起 <<
NCT00224549	Hypertension	Phase 4	Completed	-	France ... 展开 >> Investigation Clinical Center European Georges Pompidou Hospital Paris, Ile de France, France, 75015 收起 <<
NCT00005010	End-Stage Renal Disease ... 展开 >> Chronic Allograft Nephropathy 收起 <<	Phase 3	Completed	-	United States, Maryland ... 展开 >> Ilene Blechman-Krom Rockville, Maryland, United States, 20850 收起 <<
NCT03016832	Diabetic Kidney Disease	Early Phase 1	Unknown	December 2018	China, Jiangsu ... 展开 >> Jiangsu Province Hospital of TCM Recruiting Nanjing, Jiangsu, China Contact: Wei Sun +86 13505199801 jssunwei@163.com 收起 <<
NCT01968759	Chronic Kidney Disease	Phase 2	Completed	-	Italy ... 展开 >> Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Azienda Ospedaliera "Bianchi-Melacrino-Morelli" c/o Ospedali Riuniti U.O. Nefrologia, Dialisi e Trapianto Reggio Calabria, Italy 收起 <<
NCT00635232	-		Completed	-	-
NCT00742066	Hypertension ... 展开 >>Insulin Resistance Microcirculation 收起 <<	Not Applicable	Unknown	July 2009	Netherlands ... 展开 >> University Hospital Maastricht Maastricht, P.O. Box 5800, Netherlands, 6202 AZ 收起 <<
NCT00249873	Atrial Fibrillation ... 展开 >> Vascular Risk 收起 <<	Phase 3	Completed	-	-
NCT00243178	Atrial Fibrillation ... 展开 >> Vascular Risk 收起 <<	Phase 3	Terminated	-	-
NCT00635232	Hypertension	Phase 2	Completed	-	-
NCT02721342	-		Recruiting	March 2019	Italy ... 展开 >> Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò Recruiting Ranica, Bergamo, Italy, 24020 Contact: Erica Daina, MD erica.daina@marionegri.it Ospedale Morgagni - Pierantoni - U.O. Nefrologia e Dialisi Recruiting Forlì, Forli', Italy, 47011 Contact: Giovanni Mosconi, MD giovanni.mosconi@ausl.fo.it Asl 6 Sanluri-P.O. Nostra Signora di Bonaria - U.O. Nefrologia e Dialisi Recruiting San Gavino- Monreale, Medio Campidano - VS, Italy, 09037 Contact: Maria Cristina Mereu, MD mariacristina.mereu@asl6sanluri.it Ospedale C.G. Mazzoni Zona 13 ASUR Marche - U.O. Nefrologia e Dialisi Recruiting Ascoli Piceno, Italy, 63100 Contact: Mauro Ragaiolo, MD m.ragaiolo@asl13.marche.it AORN Moscati - Avellino - U.O. Nefrologia e Dialisi Recruiting Avellino, Italy, 83100 Contact: Walter De Simone, MD wadesimone@aosgmoscati.av.it A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi Recruiting Bergamo, Italy, 20147 Contact: Piero Ruggenenti, MD pruggenenti@hpg23.it A.O. Papa Giovanni XXIII Bergamo - U.O. Diabetologia Recruiting Bergamo, Italy, 20147 Contact: Roberto Trevisan, MD rtrevisan@hpg23.it Azienda Ospedaliera G. Brotzu - U.O. Nefrologia e Dialisi Recruiting Cagliari, Italy, 09100 Contact: Antonello Pani, MD antonellopani@aob.it Ospedale Campo di Marte - USL 2 - U.O. Nefrologia Recruiting Lucca, Italy, 55100 Contact: Alberto Rosati, MD arosati@usl2.toscana.it ARNAS Ospedale Civico Di Cristina Benfratelli - U.O. Nefrologia e Dialisi Recruiting Palermo, Italy, 90127 Contact: Carlo Giammarresi, MD cgiammer@tin.it Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Università degli Studi di Palermo - Dipartimento Malattie Cardiovascolari e Nefrourologiche - U.O. Tecniche Dialitiche Recruiting Palermo, Italy, 90129 Contact: Maurizio Li Vecchi, MD livecchi@unipa.it Azienda Ospedaliera Universitaria Pisana - U.O. Nefrologia e Dialisi 2 Recruiting Pisa, Italy, 56126 Contact: Giuliano Barsotti, MD g.barsotti@med.unipi.it Ospedale di Circolo Fondazione Macchi - U.O. Nefrologia e Dialisi Recruiting Varese, Italy, 21100 Contact: Gian Maria Frattini, MD gianmaria.frattini@ospedale.varese.it 收起 <<
NCT00343551	Essential Hypertension	Phase 3	Completed	-	Germany ... 展开 >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland 收起 <<
NCT01360710	Abdominal Obesity ... 展开 >> Hypertension 收起 <<	Phase 4	Unknown	-	Australia, Victoria ... 展开 >> BakerIDI Heart and Diabetes Institute Recruiting Prahran, Victoria, Australia, 3004 Contact: Markus Schlaich markus.schlaich@bakeridi.edu.au 收起 <<
NCT01109212	Diabetic Nephropathy	Phase 2	Completed	-	Italy ... 展开 >> The Mario Negri Institute for Pharmacological Research- Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 Azienda Ospedaliera di Treviglio-Caravaggio - Unità Operativa Malattie Metaboliche e Diabetologia Treviglio, Bergamo, Italy, 24047 Azienda Ospedaliera OO.RR. Bergamo - Unità Operativa Diabetologia Bergamo, Italy, 24128 IRCCS Fondazione Centro S. Raffaele del Monte Tabor- Unità Operativa Medicina Generale Milano, Italy, 20132 Ist. Patologia Medica e metodologia Clinica - Università di Sassari Sassari, Italy, 7100 Slovenia University Medical Center Dpt Endocrinology Diabetes and Metabolic Diseases- Diabetology Unit Ljubljana, Slovenia, 1000 收起 <<
NCT03493685	Focal Segmental Glomeruloscler... 展开 >>osis 收起 <<	Phase 3	Recruiting	December 2022	-
NCT01519297	Preeclampsia ... 展开 >>Pregnancy Induced Hypertension 收起 <<	Not Applicable	Recruiting	June 2018	United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 收起 <<
NCT03762850	Immunoglobulin A Nephropathy	Phase 3	Not yet recruiting	April 2023	-
NCT00249873	-		Completed	-	-
NCT01613118	Focal Segmental Glomeruloscler... 展开 >>osis 收起 <<	Phase 2	Active, not recruiting	August 2021	-
NCT00500604	Hypertension	Phase 4	Completed	-	Egypt ... 展开 >> Sanofi-Aventis Administrative Office Cairo, Egypt Hong Kong Sanofi-Aventis Administrative Office Hong Kong, Hong Kong India Sanofi-Aventis Administrative Office Mumbai, India Indonesia Sanofi-Aventis Administrative Office Jakarta, Indonesia Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Malaysia Sanofi-Aventis Administrative Office Kuala Lumpur, Malaysia Morocco Sanofi-Aventis Administrative Office Casablanca, Morocco Pakistan Sanofi-Aventis Administrative Office Karachi, Pakistan Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Singapore Sanofi-Aventis Administrative Office Singapore, Singapore Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Thailand Sanofi-Aventis Administrative Office Bangkok, Thailand Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia Vietnam Sanofi-Aventis Administrative Office Ho Chi Minh City, Vietnam 收起 <<
NCT01238705	Hypertension ... 展开 >>Sexual Dysfunction 收起 <<	Phase 4	Unknown	November 2010	China, Gansu ... 展开 >> The Second Hospital of Lanzhou University Recruiting Lanzhou, Gansu, China, 730000 Contact: Ruixin Ma, Doctor +86 13893102690 mrxdr@sina.com Contact: Jing Yu, Professor +86 13893607559 yujing2304@126.com Principal Investigator: Jing Yu, Professor Sub-Investigator: Ruixin Ma, Doctor 收起 <<
NCT02597361	Ehlers-Danlos Syndrome, Vascul... 展开 >>ar Type 收起 <<	Phase 3	Recruiting	April 2020	France ... 展开 >> CHU DE BORDEAUX - Hopital Saint Andre Recruiting Bordeaux, France, 33075 Contact: Joel CONSTANS, MD,PHD +33 5 56 79 57 16 joel.constans@chu-bordeaux.fr CHU DE LYON - Hopital Femme Mere Enfant Recruiting Bron, France, 69500 Contact: Sophie DUPUIS-GIROD, MD,PHD +33 4 27 85 65 24 sophie.dupuis-girod@chu-lyon.fr CHU DE CAEN - Hopital Cote de Nacre Recruiting Caen, France, 14033 Contact: Damien LANEELLE, MD,PHD +33 2 31 06 53 27 laneelle-d@chu-caen.fr CHU DE TOURS - Hopital Trousseau Not yet recruiting Chambray-les-Tours, France, 37044 Contact: Gabriela GEORGESCOU, MD +33 2 47 47 46 25 g.georgescou@chu-tours.fr CHU DE GRENOBLE - Hopital Albert Michallon Recruiting Grenoble, France, 38043 Contact: Christophe SEINTURIER, MD,PHD +33 4 76 76 89 60 cseinturier@chu-grenoble.fr CHU DE GRENOBLE - Hopital Couple Enfant Not yet recruiting Grenoble, France, 38043 Contact: Pierre-Simon JOUK, MD,PHD +33 7 76 76 72 85 psjouk@chu-grenoble.fr CHRU DE LILLE - Hopital Claude Huriez Recruiting Lille, France, 59000 Contact: Marc LAMBERT, MD +33 3 20 44 42 96 marc.lambert@chru-lille.fr CHU DE LYON - Hopital Edouard Herriot Not yet recruiting Lyon, France, 69003 Contact: Jacques NINET, MD,PHD +33 4 72 11 75 71 jacques.ninet@chu-lyon.fr AP-HM - Hopital de la Timone Recruiting Marseille, France, 13385 Contact: Laurence BAL-THEOLEYRE, MD +33 4 91 38 81 20 laurence.bal@ap-hm.fr CHU DE MONTPELLIER - Hopital Saint Eloi Recruiting Montpellier, France, 34295 Contact: Isabelle QUERE, MD,PHD +33 67 33 70 25 i-quere@chu-montpellier.fr CHU DE NANTES - Hopital Hotel-Dieu Not yet recruiting Nantes, France, 44300 Contact: Marc-Antoine PISTORIUS, MD +33 2 40 08 33 34 marc.pistorius@chu-nantes.fr AP-HP - Hopital Europeen Georges-Pompidou Recruiting Paris, France, 75015 Contact: Xavier JEUNEMAITRE, MD,PHD +33 1 56 09 38 80 xavier.jeunemaitre@aphp.fr Contact: Michael FRANK, MD +33 1 56 09 50 40 michael.frank@aphp.fr CHU DE TOULOUSE - Hopital Purpan Not yet recruiting Toulouse, France, 31059 Contact: Sophie JULIA, MD +33 5 61 77 90 55 julia.s@chu-toulouse.fr CHU DE TOULOUSE - Hopital Rangueil Recruiting Toulouse, France, 31059 Contact: Alessandra BURA-RIVIERE, MD,PHD +33 5 61 32 24 38 bura-riviere.a@chu-toulouse.fr CHRU DE NANCY - Institut Lorrain du Coeur et des Vaisseaux Recruiting Vandoeuvre-les-Nancy, France, 54500 Contact: Denis WAHL, MD,PHD +33 3 83 15 36 14 d.wahl@chu.nancy.fr 收起 <<
NCT00219115	Hypertension	Phase 3	Completed	-	United States, New Jersey ... 展开 >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany 收起 <<
NCT00264212	Hypertension	Phase 4	Completed	-	Chile ... 展开 >> Sanofi-Aventis Santiago, Chile China Sanofi-Aventis Shangai, China Indonesia Sanofi-Aventis Jakarta, Indonesia Korea, Republic of Sanofi-Aventis Seoul, Korea, Republic of Mexico Sanofi-Aventis Mexico, Mexico Philippines Sanofi-Aventis Manila, Philippines Taiwan Sanofi-Aventis Taipei, Taiwan Thailand Sanofi-Aventis Bangkok, Thailand 收起 <<
NCT03006796	-		Recruiting	June 2019	Russian Federation ... 展开 >> City Hospital №5 Recruiting Moscow, Russian Federation, 107015 Contact: Elena Y Shupenina, PhD +74992684459 收起 <<
NCT01949233	Marfan Syndrome	Phase 2	Unknown	December 2017	United Kingdom ... 展开 >> John Radcliffe Hospital Recruiting Oxford, Oxfordshire, United Kingdom, OX3 9DU Sub-Investigator: Edward Blair, MBChB MRCP Sub-Investigator: Paul Wordsworth, MB FRCP University of Oxford Recruiting Oxford, Oxfordshire, United Kingdom, OX3 9DU Sub-Investigator: Alex Pitcher, DPhil, MA, BM BCh, MRCP Sub-Investigator: Andrew Lewis, MB BS MRes MRCP Sub-Investigator: Hayley Harvey Sub-Investigator: Stefan Neubauer, MD FRCP FACC FMedSci Sub-Investigator: Paul Leeson Sub-Investigator: Jacqueline Birks 收起 <<
NCT01992796	Severe Sepsis	Phase 3	Unknown	January 2017	Italy ... 展开 >> Università di Salerno Not yet recruiting Salerno, Italy Contact: Ornella Piazza Principal Investigator: Ornella Piazza 收起 <<
NCT00660309	Type 2 Diabetes Mellitus	Phase 4	Completed	-	United States, Massachusetts ... 展开 >> Novartis Investigator Site Boston, Massachusetts, United States, 02115 收起 <<
NCT00350038	Hypertension ... 展开 >>Dyslipidemia 收起 <<	Phase 4	Completed	-	Hungary ... 展开 >> Sanofi-aventis Budapest, Hungary 收起 <<
NCT01082835	-		Unknown	August 2010	China, Beijing ... 展开 >> Beijing Medical University ,Dongzhimen Hospital Not yet recruiting Beijing, Beijing, China Contact: Weixing Lu 0086-013601067938 weixinglu918@sina.com Beijing Medical University,Dongfang Hospital Not yet recruiting Beijing, Beijing, China Contact: Qian Lin 0086-013910565673 dfluyao@126.com China Academy of Chinese Medical Sciences,Guang'anmen Hospital Not yet recruiting Beijing, Beijing, China Contact: Qiang Zhou 0086-015101016416 tiantianlanzhouqiang@126.com Chinese Academy of Medical Sciences Fu Wai Cardiovascular Hospital Not yet recruiting Beijing, Beijing, China Contact: Jianfeng Huang 0086-010-88396403 jianfhuang918@sina.com Capital University of Medical, Anzhen Hospital Not yet recruiting Beijng, Beijing, China Contact: Zhenqiu Yu 0086-010-64456577 yuzhenqiu@yahoo.com.cn 收起 <<
NCT00171080	Hypertension	Phase 3	Completed	-	Germany ... 展开 >> Investigative Centers, Germany Switzerland Novartis Pharmaceuticals Basel, Switzerland 收起 <<
NCT00950066	Hypertension	Phase 2	Completed	-	India ... 展开 >> Sanofi-Aventis Administrative Office Mumbai, India Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan 收起 <<
NCT00185055	Healthy	Phase 4	Completed	-	-
NCT00154024	Healthy Subjects	Not Applicable	Completed	-	Germany ... 展开 >> Institute of Clinical Pharmacology, Medical Faculty, University of Technology Dresden, Germany, 01307 收起 <<
NCT00561964	Hypertension	Phase 3	Completed	-	-
NCT00708344	Hypertension	Phase 4	Completed	-	Algeria ... 展开 >> Sanofi-Aventis Administrative Office Algiers, Algeria Argentina Sanofi-Aventis Administrative Office Buenos Aires, Argentina Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Colombia Sanofi-Aventis Administrative Office Bogota, Colombia Ecuador Sanofi-Aventis Administrative Office Quito, Ecuador Egypt Sanofi-Aventis Administrative Office Cairo, Egypt Guatemala Sanofi-Aventis Administrative Office Guatemala City, Guatemala Lebanon Sanofi-Aventis Administrative Office Beirut, Lebanon Mexico Sanofi-Aventis Administrative Office Col. Coyoacan, Mexico Morocco Sanofi-Aventis Administrative Office Casablanca, Morocco Panama Sanofi-Aventis Administrative Office Panama, Panama Peru Sanofi-Aventis Administrative Office Lima, Peru Saudi Arabia Sanofi-Aventis Administrative Office Jeddah, Saudi Arabia Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia United Arab Emirates Sanofi-Aventis Administrative Office Dubaï, United Arab Emirates Venezuela Sanofi-Aventis Administrative Office Caracas, Venezuela 收起 <<
NCT00125645	Myocardial Infarction	Phase 4	Completed	-	Denmark ... 展开 >> Kardiologisk Klinik, Centralsygehuset Esbjerg/Varde Esbjerg, Denmark, 6700 收起 <<
NCT01442987	Hypertension ... 展开 >>Hyperlipidemia 收起 <<	Phase 3	Completed	-	Korea, Republic of ... 展开 >> 16 institutions including Seoul National University Hospital Seoul, Korea, Republic of 收起 <<
NCT00660309	-		Completed	-	-
NCT03627715	Diabetic Kidney Disease	Phase 2	Recruiting	October 2019	Australia, New South Wales ... 展开 >> Renal Research Recruiting Gosford, New South Wales, Australia Contact: Simon Rogers Liverpool Hospital Recruiting Liverpool, New South Wales, Australia, 2170 Contact: Michael Suranyi Royal North Shore Hospital Recruiting St Leonards, New South Wales, Australia, 2065 Contact: Carol Pollock Westmead Hospital Recruiting Westmead, New South Wales, Australia, 2145 Contact: Richard Phoon Australia, Queensland Sunshine Coast University Hospital Not yet recruiting Birtinya, Queensland, Australia, 4575 Contact: Nicholas Gray Princess Alexandra Hospital Recruiting Woolloongabba, Queensland, Australia, 4102 Contact: David Mudge Australia, Victoria Boxhill Hospital Recruiting Box Hill, Victoria, Australia, 3128 Contact: Matthew Roberts Austin Hospital Recruiting Heidelberg, Victoria, Australia, 3084 Contact: David Power Sunshine Hospital Recruiting Melbourne, Victoria, Australia, 3021 Contact: Craig Nelson Epworth Hospital Recruiting Richmond, Victoria, Australia, 3121 Contact: Ian Fraser 收起 <<
NCT00095238	Congestive Heart Failure	Phase 3	Completed	-	-
NCT00265642	Hepatitis C, Chronic	Phase 3	Completed	-	France ... 展开 >> CHU Angers, Service d'hépato-gastroentérologie Angers, France, 49933 cedex 09 收起 <<
NCT00335673	Hypertension	Phase 4	Completed	-	Egypt ... 展开 >> Sanofi-Aventis Administrative Office Cairo, Egypt 收起 <<
NCT03649152	Focal Segmental Glomeruloscler... 展开 >>osis 收起 <<	Phase 2	Recruiting	December 2019	Australia, New South Wales ... 展开 >> Renal Research Recruiting Gosford, New South Wales, Australia, 2250 Contact: Simon Roger Liverpool Hospital Recruiting Liverpool, New South Wales, Australia, 2170 Contact: Michael Suranyi Royal North Shore Hospital Recruiting St Leonards, New South Wales, Australia, 2065 Contact: Carol Pollock Westmead Recruiting Westmead, New South Wales, Australia, 2145 Contact: Richard Phoon Australia, Queensland Sunshine Coast University Hospital Recruiting Birtinya, Queensland, Australia, 4575 Contact: Nicholas Gray Princess Alexandra Hospital Recruiting Woolloongabba, Queensland, Australia, 4102 Contact: David Mudge Australia, Victoria Box Hill Hospital Recruiting Box Hill, Victoria, Australia, 3128 Contact: Matthew Roberts Austion Hospital Recruiting Heidelberg, Victoria, Australia, 3084 Contact: David Power Sunshine Hospital Recruiting Melbourne, Victoria, Australia, 3021 Contact: Craig Nelson Epworth Hospital Recruiting Richmond, Victoria, Australia, 3121 Contact: Ian Fraser 收起 <<
NCT00095238	-		Completed	-	-
NCT00347087	Chronic Heart Failure	Phase 4	Completed	-	Germany ... 展开 >> Applied Cachexia Research, Cardiology Dept. Charite Medical School, Virchow Klinikum Berlin, Germany 收起 <<
NCT01625494	Hypertension	Phase 3	Completed	-	Russian Federation ... 展开 >> Sanofi-Aventis Administrative Office Moscow, Russian Federation 收起 <<
NCT00296218	Myocardial Ischemia ... 展开 >> Hypertension 收起 <<	Phase 3	Completed	-	United States, New Jersey ... 展开 >> Sanofi-Aventis Bridgewater, New Jersey, United States Belgium Sanofi-Aventis Brussels, Belgium Canada Sanofi-Aventis Laval, Canada France Sanofi-Aventis Paris, France Germany Sanofi-Aventis Berlin, Germany Hungary Sanofi-Aventis Budapest, Hungary Italy Sanofi-Aventis Milan, Italy Netherlands Sanofi-Aventis Gouda, Netherlands Spain Sanofi-Aventis Barcelona, Spain Switzerland Sanofi-Aventis Meyrin, Switzerland United Kingdom Sanofi-Aventis Guildford, United Kingdom 收起 <<
NCT00670566	Hypertension	Phase 4	Completed	-	China ... 展开 >> Sanofi-Aventis Administrative Office Shanghai, China 收起 <<
NCT02148991	-		Completed	-	Greece ... 展开 >> Georgios Gennimatas General State Hospital Athens, Holargos, Greece, 11527 Georgios Gennimatas General State Hospital Athens, Greece, 10682 收起 <<
NCT00225667	Atrial Fibrillation ... 展开 >> Hypertension 收起 <<	Phase 3	Unknown	-	Canada, Ontario ... 展开 >> Population Health Research Institute of McMaster University Not yet recruiting Hamilton, Ontario, Canada, L8L 2X2 Contact: Ellison J. Themeles, MSc. 905-527-4322 ext 44713 themelese@ccc.mcmaster.ca Principal Investigator: Stuart J. Connolly, MD 收起 <<
NCT00529750	Hypertension	Phase 4	Completed	-	-
NCT00283036	Hypertension	Phase 4	Completed	-	Algeria ... 展开 >> Sanofi-Aventis Alger, Algeria 收起 <<
NCT00562809	Hypertension	Phase 4	Completed	-	United States, New Jersey ... 展开 >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 收起 <<
NCT01858610	Healthy	Not Applicable	Completed	-	Egypt ... 展开 >> Pharmaceutics Department, Faculty of Pharmacy, Damanhour University Damanhour, Egypt 收起 <<
NCT00320879	Type 2 Diabetes ... 展开 >> Microalbuminuria 收起 <<	Phase 4	Completed	-	Denmark ... 展开 >> Steno Diabetes Center Gentofte, Copenhagen, Denmark, 2820 收起 <<
NCT00464880	Diabetes Type 2	Phase 1 Phase 2	Completed	-	Denmark ... 展开 >> Novartis Gentofte, Denmark, 2820 收起 <<
NCT00362037	Hypertension	Phase 4	Completed	-	Egypt ... 展开 >> Sanofi-Aventis Administrative Office Cairo, Egypt 收起 <<
NCT00317915	Type 2 Diabetes ... 展开 >> Microalbuminuria Hypertension 收起 <<	Phase 3	Completed	-	-
NCT00095550	Hypertension	Phase 3	Completed	-	-
NCT00152698	Hypercholesterolemia	Phase 3	Completed	-	Germany ... 展开 >> CRC, Medizinsiche Klinik 4, Nephrology and Hypertension, University of Erlangen-Nürnberg Erlangen, Bavaria, Germany, 91054 收起 <<
NCT00110422	Metabolic Syndrome ... 展开 >> Hypertension 收起 <<	Phase 4	Completed	-	France ... 展开 >> Local Institution Angers, France Local Institution Nantes, France Local Institution Tierce, France Germany Local Institution Hannover, Germany Local Institution Muenchen, Germany Local Institution Ornbau, Germany Local Institution Rotenburg An De Fluda, Germany Local Institution Tuebingen, Germany Local Institution Villingen-Schwenningen, Germany Italy Local Institution Ancona, Italy Local Institution Chieti Scalo, Italy Local Institution Pisa, Italy Local Institution Ravenna, Italy Local Institution Sassari, Italy Norway Local Institution Oslo, Norway Local Institution Snaroya, Norway Russian Federation Local Institution Moscow, Russian Federation Local Institution Saratov, Russian Federation Local Institution St. Petersburg, Russian Federation Local Institution Yaroslavl, Russian Federation Spain Local Institution A Coruna, Spain Local Institution Barcelona, Spain Local Institution Granada, Spain Local Institution Sevilla, Spain Local Institution Zaragoza, Spain 收起 <<
NCT00362258	Hypertension	Phase 4	Completed	-	Egypt ... 展开 >> Sanofi-Aventis Administrative Office Cairo, Egypt 收起 <<
NCT00847834	Hypertension	Phase 4	Completed	-	China ... 展开 >> Sanofi aventis administrative office Beijing, China 收起 <<
NCT00095290	Albuminuria	Phase 4	Completed	-	-
NCT00334581	Hypertension	Phase 4	Completed	-	China ... 展开 >> Sanofi-Aventis Administrative Office Shanghai, China 收起 <<
NCT00956644	Hypertension	Phase 3	Completed	-	-
NCT00389168	-		Completed	-	-
NCT00517322	Left Atrial Volume ... 展开 >> Hypertensive Heart Disease Antihypertensive Drugs Diastolic Function Renin Angiotensin System 收起 <<	Phase 4	Unknown	August 2010	Italy ... 展开 >> University of Insubria-Department of Clinical Medicine Recruiting Varese, Italy, 21100 Contact: anna maria grandi, MD +39+332 278594 amgrandi@libero.it Contact: anna maria grandi, MD +39 + 332 278594 amgrandi@libero.it Sub-Investigator: andrea maria maresca, MD Sub-Investigator: andrea bertolini, MD Sub-Investigator: monica gianni, MD Sub-Investigator: eleonora nicolini, MD 收起 <<
NCT00389168	Hypertension	Phase 2 Phase 3	Completed	-	Sweden ... 展开 >> Karolinska Institutet, Daprtment of Clinical Sciences, Danderyd Hospital, Cardiovascular Research Laboratory Stockholm, Sweden, SE-182 88 收起 <<
NCT00249795	Atrial Fibrillation ... 展开 >> Cardiovascular Disease 收起 <<	Phase 3	Completed	-	-
NCT00791830	Kidney Failure, Chronic	Phase 3	Completed	-	Denmark ... 展开 >> Department of Nephrology, Aarhus University, Aalborg Aalborg, Denmark, 9000 Department of Nephrology, Aarhus University Hospital, Skejby Aarhus N, Denmark, 8200 Department of Medicine, Fredericia Hospital Fredericia, Denmark, 7000 Haemodialysis unit, Horsens Hospital Horsens, Denmark, 8700 Hemodialysis Unit, Randers Hospital Randers, Denmark, 8600 Department of Medicine M, Viborg Hospital Viborg, Denmark, 8800 收起 <<
NCT00263003	Hypertension	Phase 3	Completed	-	Taiwan ... 展开 >> Sanofi-Aventis Taipei, Taiwan 收起 <<
NCT01712126	Hypertension	Not Applicable	Completed	-	United States, Texas ... 展开 >> Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research) San Antonio, Texas, United States, 78217 收起 <<
NCT00249795	-		Completed	-	-
NCT00564187	Hypertension	Phase 4	Completed	-	Tunisia ... 展开 >> Sanofi-Aventis Megrine, Tunisia 收起 <<
NCT01712100	Hypertension	Not Applicable	Completed	-	United States, Texas ... 展开 >> Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research) San Antonio, Texas, United States, 78217 收起 <<
NCT00095394	Hypertension	Phase 3	Completed	-	-
NCT01712113	Hypertension	Not Applicable	Completed	-	United States, Texas ... 展开 >> Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research) San Antonio, Texas, United States, 78217 收起 <<
NCT00957554	Hypertension	Phase 3	Completed	-	-
NCT00265967	Hypertension	Phase 4	Completed	-	Turkey ... 展开 >> Sanofi-Aventis Istanbul, Turkey 收起 <<
NCT00613496	Persistent Atrial Fibrillation	Phase 4	Unknown	May 2010	Germany ... 展开 >> University Hospital Magdeburg; Div. of Cardiology Recruiting Magdeburg, Germany, 39120 Contact: Veronika Raetzel 0049 391 6701 veronika.raetzel@medizin.uni-magdeburg.de 收起 <<
NCT00443612	Hypertension	Phase 4	Completed	-	Taiwan ... 展开 >> Sanofi-Aventis Taipei, Taiwan 收起 <<
NCT01712139	Hypertension	Not Applicable	Completed	-	United States, Texas ... 展开 >> Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research) San Antonio, Texas, United States, 78217 收起 <<
NCT01825850	Healthy	Phase 1	Completed	-	Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Korea, Republic of 收起 <<
NCT00987662	Obesity Hyper... 展开 >>tension 收起 <<	Phase 4	Withdrawn(no funding)	January 2014	Greece ... 展开 >> Hypertension-24h ABPM Center Papageorgiou Hospital Thessaloniki, Greece 收起 <<
NCT02842359	Type 2 Diabetes Mellitus	Phase 4	Completed	-	Korea, Republic of ... 展开 >> Korea Seoul, Korea, Republic of 收起 <<
NCT03147677	Type 2 Diabetic Nephropathy	Phase 4	Recruiting	December 2018	China, Hunan ... 展开 >> The Third Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410000 Contact: Hao Zhang, Doctor +86-13975806919 zhanghaoliaoqing@163.com Hunan Chenzhou NO.1 People's Hospital Recruiting Chenzhou, Hunan, China, 423000 Contact: Xiangpin Liao, bachelor +81-13507359887 13507359887@139.com Hunan Yiyang Central Hospital Recruiting Yiyang, Hunan, China, 413000 Contact: Xiaohua Deng, bachelor +81-13707370981 yoyotyz@126.com 收起 <<
NCT00352560	Atrial Fibrillation	Phase 3	Completed	-	Spain ... 展开 >> Local Institution Madrid, Spain, 28040 Local Institution Madrid, Spain, 28046 Local Institution Madrid, Spain, 28905 收起 <<
NCT03476603	-		Recruiting	October 2026	Norway ... 展开 >> St. Olavs University Hospital Recruiting Trondheim, Norway Contact: Magnus Strømmen, MSc 收起 <<
NCT01447797	Healthy	Phase 1	Completed	-	Korea, Republic of ... 展开 >> Korea University Anam Hospital Seoul, Korea, Republic of 收起 <<
NCT00549133	Hypertension ... 展开 >>Diabetes Mellitus Type 2 收起 <<	Phase 4	Completed	-	Turkey ... 展开 >> Sanofi-Aventis Istanbul, Turkey 收起 <<
NCT02386293	Hypertension ... 展开 >>Obesity Stress, Psychological Blood Pressure 收起 <<	Phase 2	Recruiting	May 2019	United States, Georgia ... 展开 >> Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Kimberly Norland 706-721-1755 knorland@augusta.edu Contact: Sandra Young-Mayes, BS 7067211755 syoungmayes@augusta.edu Principal Investigator: Gregory A Harshfield, PhD Sub-Investigator: Ryan A Harris, PhD Sub-Investigator: Yanbin Dong, MD, PhD 收起 <<

CAS号	138402-11-6
分子式	C₂₅H₂₈N₆O
分子量	428.529

别名	厄贝沙坦 ;BMS-186295;SR-47436
运输	蓝冰

伊贝沙坦 /Irbesartan 95%

Irbesartan 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Irbesartan 质控信息

Irbesartan 生物活性

Irbesartan 临床研究

Irbesartan 参考文献

Irbesartan 实验方案

Irbesartan 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

伊贝沙坦 /Irbesartan 95%

Irbesartan 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Irbesartan 质控信息

Irbesartan 生物活性

Irbesartan 临床研究

Irbesartan 参考文献

Irbesartan 实验方案

Irbesartan 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Irbesartan 纯度/质量文件产品仅供科研